Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review
Top Cited Papers
- 1 May 2002
- journal article
- review article
- Published by Elsevier BV in Human Pathology
- Vol. 33 (5), 478-483
- https://doi.org/10.1053/hupa.2002.124123
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Rectum and AnusThe American Journal of Surgical Pathology, 2001
- Gastrointestinal Autonomic Nerve TumorThe American Journal of Surgical Pathology, 2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorThe New England Journal of Medicine, 2001
- Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosisVirchows Archiv, 2001
- Immunohistochemical Spectrum of GISTs at Different Sites and Their Differential Diagnosis with a Reference to CD117 (KIT)Laboratory Investigation, 2000
- Esophageal Stromal TumorsThe American Journal of Surgical Pathology, 2000
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Prognostic Factors Influencing Survival in Gastrointestinal Leiomyosarcomas Implications for Surgical Management and StagingAnnals of Surgery, 1992